CCM
Camber Capital Management Portfolio holdings
AUM
$718M
1-Year Return
4.23%
This Quarter Return
+9.09%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.69B
AUM Growth
-$38.6M
(-2.2%)
Cap. Flow
-$160M
Cap. Flow
% of AUM
-9.49%
Top 10 Holdings %
Top 10 Hldgs %
62.77%
Holding
41
New
5
Increased
5
Reduced
7
Closed
8
Top Buys
| 1 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
$59.9M |
| 2 |
Sarepta Therapeutics
SRPT
|
$40M |
| 3 |
Gilead Sciences
GILD
|
$27.2M |
| 4 |
Puma Biotechnology
PBYI
|
$24.2M |
| 5 |
ELGX
Endologix Inc
ELGX
|
$17.1M |
Top Sells
| 1 |
Biogen
BIIB
|
$49.6M |
| 2 |
UAM
Universal American Corp
UAM
|
$48.5M |
| 3 |
CONMED
CNMD
|
$33.1M |
| 4 |
ATHN
Athenahealth, Inc.
ATHN
|
$31.6M |
| 5 |
Perrigo
PRGO
|
$26.6M |
Sector Composition
| 1 | Healthcare | 86.79% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BIOL
26
DELISTED
Biolase, Inc.
BIOL
| $7.2M | 0.29% |
427
| – | – |
|
|
ARNA
27
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $6.21M | 0.25% |
425,000
| – | – |
|
28
Atara Biotherapeutics
ATRA
$90.7M
| $2.57M | 0.1% |
+5,000
| New | +$2.57M |
|
|
DXTR
29
DELISTED
Dextera Surgical Inc.
DXTR
| $888K | 0.04% |
837,483
| – | – |
|
30
Astria Therapeutics
ATXS
$424M
| – | – |
-16,667
| Closed | -$3.61M |
|
|
31
Biogen
BIIB
$20.6B
| – | – |
-175,000
| Closed | -$49.6M |
|
32
Centene
CNC
$14.2B
| – | – |
-400,000
| Closed | -$11.3M |
|
|
33
CONMED
CNMD
$1.7B
| – | – |
-750,000
| Closed | -$33.1M |
|
34
SPDR S&P 500 ETF Trust
SPY
$660B
| – | – |
0
| – | – |
|
35
Stryker
SYK
$150B
| – | – |
0
| – | – |
|
|
AMAG
36
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| – | – |
-611,390
| Closed | -$21.3M |
|
|
ATHN
37
DELISTED
Athenahealth, Inc.
ATHN
| – | – |
-300,000
| Closed | -$31.6M |
|
|
UAM
38
DELISTED
Universal American Corp
UAM
| – | – |
-4,875,000
| Closed | -$48.5M |
|